New hope for advanced colon cancer: drug combo shows promise in second-line trial
NCT ID NCT07011576
First seen Oct 31, 2025 · Last updated May 09, 2026 · Updated 32 times
Summary
This study tests a combination of two cancer drugs (fruquintinib and FOLFIRI) as a second treatment option for people with metastatic colorectal cancer whose first treatment stopped working. About 60 adults will receive the drug combo to see if it can slow cancer growth and how safe it is. The goal is to find a better way to control the disease when initial therapy fails.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alliance Cancer Specialists
RECRUITINGWynnewood, Pennsylvania, 19096, United States
-
Blue Ridge Cancer Care (Oncology & Hematology Associates of Southwest VA)
RECRUITINGSalem, Virginia, 24153, United States
-
Illinois Cancer Specialists
RECRUITINGArlington Heights, Illinois, 60005, United States
-
Maryland Oncology Hematology
RECRUITINGColumbia, Maryland, 21044, United States
-
Minnesota Oncology Hematology - Primary
RECRUITINGMaple Grove, Minnesota, 55369, United States
-
Missouri Cancer Associates
RECRUITINGColumbia, Missouri, 65201, United States
-
Northwest Cancer Specialists - Compass
RECRUITINGPortland, Oregon, 97213, United States
-
Oncology Associates of Oregon - Primary
RECRUITINGEugene, Oregon, 97401, United States
-
Rocky Mountain Cancer Center - Primary
RECRUITINGDenver, Colorado, 80218, United States
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
Texas Oncology - Central/South Texas
RECRUITINGAustin, Texas, 78705, United States
-
Texas Oncology - Gulf Coast
RECRUITINGBeaumont, Texas, 77702, United States
-
Texas Oncology - Northeast Texas
RECRUITINGTyler, Texas, 75702, United States
-
Virginia Oncology Associates
RECRUITINGNorfolk, Virginia, 23502, United States
Conditions
Explore the condition pages connected to this study.